As a research center embedded within Kaiser Permanente’s large and dynamic health care system, our investigators have a unique opportunity to apply scientific expertise to real-world clinical problems, translate findings into practice, and share what we learn with the broader community.
Dr. Michael Girvigian is a radiation oncologist, assistant chief of the Department of Radiation Oncology, and co-director of the image-guided radiosurgery program for the Kaiser Permanente Los Angeles Medical Center and the Southern California Permanente Medical Group. His clinical focus is on the management of benign and malignant tumors of the brain and spine with the use of image-guided radiosurgery and radiotherapy. He also introduced the use of stereotactic body radiotherapy in the organization ...
Being active can lower your risk of getting seriously ill with COVID, regardless of your race or the chronic conditions you may have, according to research published last year in the American Journal of Preventive Medicine.
The Kaiser Permanente Southern California findings were important, impactful, and influential. As a result, the journal editors chose the research article, “Associations of Physical Inactivity and COVID-19 Outcomes Among Subgroups,” as the American Journal of Preventive Medicine 2023 Article of the Year.
A new study by Kaiser Permanente has shown that the ABRYSVO respiratory syncytial virus vaccine is very effective in reducing emergency room visits and hospital stays due to RSV among older adults. “This Kaiser Permanente research demonstrated the real-world effectiveness of RSV vaccination among those 60 and over,” said lead author Sara Y. Tartof, PhD, ...
Exposure to a specific kind of air pollution, fine particulate matter, during pregnancy may significantly increase the risk of spontaneous preterm birth, which can be dangerous for both the mother and the baby, according to a Kaiser Permanente study published in JAMA Network Open. “Consistent with other study findings, this current study has demonstrated that ...
Javed Sheikh, MD, was recently named 2024 Physician Researcher of the Year by the Southern California Permanente Medical Group. Dr. Sheikh is the vice area research chair for the Los Angeles area on the Regional Research Committee. He is chief of the Department of Allergy and Immunology at the Kaiser Permanente Los Angeles Medical Center ...
After COVID-19 vaccines became available in December 2020, several smartphone-based reporting systems were developed to monitor vaccine side effects. They included V-safe from the Centers for Disease Control and Prevention. However, like most large surveillance systems, they had imperfections. Kaiser Permanente Southern California collaborated with the CDC and others to create a new system in ...
Research conducted at Kaiser Permanente has provided reassurance to the public and lawmakers by refuting claims that COVID-19 vaccines may increase the risk of cardiac-related death. “Our work reaffirms the previously established safety of COVID-19 vaccines,” said lead author Stanley Xu, PhD, of the Kaiser Permanente Southern California Department of Research & Evaluation. The study addressed ...
In our newest edition of IMPACT, we share some of our recent research including one study about the effectiveness of the side-effect monitor our researchers developed during the early days of COVID that has gone onto being used to get feedback on other vaccines. Another study examined issues with chronic kidney disease, and the story reveals how that research has gone onto change practice. Other stories focus on research into air pollution and the risk of preterm birth, younger adults and colon cancer screening outreach, opioid use among breast cancer survivors and the risk of falls, COVID vaccines, and heart failure. We’ve also got 2 Q&As, one with the 2024 physician researcher of the year and one with the director of our Division of Epidemiologic Research.
The Division of Clinical Trials Research advances medical innovation by supporting evaluation of new drugs, therapies, and devices to prevent and treat health problems. Our physician investigators work with cooperative groups and industry sponsors to conduct clinical trials for investigational drugs, biologics, and devices. In addition, the division develops pragmatic trials that help answer questions about care delivery.
The region has clinical trials programs in oncology (adult, gynecologic, pediatric, and surgical/radiation oncology), urology, gynecology, neurology, dermatology, metabolic diseases, nephrology, ophthalmology, infectious disease, cardiology, hepatology, vascular surgery, and rheumatology. Clinical trials staff support trials at medical centers and medical office buildings throughout the Kaiser Permanente Southern California Region.